SavedAdd your journal

Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 4

Diagnostic biomarkers of acute exacerbation of chronic obstructive pulmonary disease at elderly patients

Yakup ARSLAN
Deniz DOGAN
Pages
847–851
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results would help us to consider the use of prohormone brain natriuretic peptide levels as a diagnostic biomarker for verifying the diagnosis of acute exacerbation of chronic obstructive pulmonary disease and predicting the length of hospital stay at elderly patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute exacerbations of chronic obstructive pulmonary disease are caused by a variety of different etiologies.
📊
Key Findings & Data:The f iles of 120 patients who had been hospitalized with the diagnose of acute exacerbation of chronic obstructive pulmonary disease between January 2017 to December 2018 in the Chest Disease Department of Gulhane Education and Training Hospital were examined retrospectively.
💡
Conclusion & Impact:These results would help us to consider the use of prohormone brain natriuretic peptide levels as a diagnostic biomarker for verifying the diagnosis of acute exacerbation of chronic obstructive pulmonary disease and predicting the length of hospital stay at elderly patients.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Özet

Acute exacerbations of chronic obstructive pulmonary disease are caused by a variety of different etiologies. The aim of the current study was to determine the diagnostic biomarkers for verifying the diagnosis of acute exacerbations of chronic obstructive pulmonary disease and predicting the length of hospital stay at elderly patients. The f iles of 120 patients who had been hospitalized with the diagnose of acute exacerbation of chronic obstructive pulmonary disease between January 2017 to December 2018 in the Chest Disease Department of Gulhane Education and Training Hospital were examined retrospectively. The numbers and the percentage of male and female patients were 83 (% 69) and 37 (% 31) respectively. Increases in the prohormone brain natriuretic peptide values of elderly patients were found as statistically significant (p<0.001). Statistically significant positive correlation between the lengths of hospital stay with the prohormone brain natriuretic peptide values was found at elderly patients group (r=0.336, p=0.001). Also statistically significant positive correlation was found between high sensitive C-reactive protein values with procalcitonin and neutrophil/ lymphocyte ratio (r=0.320, p=0.001 and r=0.257, p=0.006, respectively). Our study indicates significantly higher values of prohormone brain natriuretic peptide levels at elderly patients in accordance with length of hospital stay. These results would help us to consider the use of prohormone brain natriuretic peptide levels as a diagnostic biomarker for verifying the diagnosis of acute exacerbation of chronic obstructive pulmonary disease and predicting the length of hospital stay at elderly patients.

🔖

Cite This Article

ARSLAN, Y., DOGAN, D. (2019). Diagnostic biomarkers of acute exacerbation of chronic obstructive pulmonary disease at elderly patients. Medicine Science, Cilt: 8 - Sayı: 4, 847–851. https://ajindex.com/articles/277163

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5:020415. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347-65.
  2. Quon BS, Gan WQ, Sin DD. Contemporary Management of Acute Exacerbations of COPD: A Systematic Review and Metaanalysis. Chest. 2008;133:756-66.
  3. Leuppi JD, Schuetz P, Bingisser R, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The reduce randomized clinical trial. JAMA. 2013;309:2223-31.
  4. Aaron SD, Donaldson GC, Whitmore GA, et al. Time course and pattern of COPD exacerbation onset. Thorax. 2012;67:238-43.
  5. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:209-10.
  6. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38:2935. Jones PW, Harding G, Berry P, Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648-54. 10. Lee SD, Huang MS, Kang J, et al. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014;108:600-8. 11. Jones PW, Adamek L, Nadeau G, et al. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42:647-54. 12. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9. 13. Dickstein K, Cohen-Solal A, Filippatos G, et al; ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-442. 14. Calzetta L, Orlandi A, Page C, et al. Brain natriuretic peptide: Much more than a biomarker. Int J Cardiol. 2016;221:1031-8. 15